Recent Press Releases

ONGLYZA(R) Becomes the First DPP-4 Inhibitor Available for Use in Europe

PARIS and LONDON, March 4, 2011 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (http://www.bms.com)(NYSE: BMY) and AstraZeneca (http://www.astrazeneca.com) (NYSE: AZN)today announced that the

Amgen to Present at the Cowen and Company 31st Annual Healthcare Conference

THOUSAND OAKS, Calif., March 3, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) will present at the Cowen and Company 31st Annual Healthcare Conference on Tuesday, March 8, 2011 at the Boston Marriott

Vertex Announces Webcast of its Presentation at the Cowen 31st Annual Health Care Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its presentation at the Cowen 31st Annual Health Care Conference on Monday,

Flamel Technologies Announces Fourth Quarter and Year-End 2010 Results

Fourth quarter highlights include achievement of key milestones with Merck Serono for development of long-acting formulation of interferon beta 1-a LYON, France--(BUSINESS WIRE)-- Flamel Technologies

Educational Efforts Reduce COPD Costs by $3.4 Million in East Texas Study

Report shows decreased hospitalizations FORT WORTH, Texas, March 3, 2011 /PRNewswire-USNewswire/ -- A new report released by the UNT Health Science Center shows that residents of 12 counties in East

Forest Pharmaceuticals Sentenced to Pay $164 Million for Criminal Violations

Forest Pharmaceuticals Sentenced to Pay $164 Million for Criminal ViolationsWASHINGTON -- Drug manufacturer Forest Pharmaceuticals Inc. was sentenced today by U.S. District Judge Nancy Gertner to pay

Breakaway From Cancer® Launches Newly-Enhanced Website Offering Comprehensive, Tailored Support for Cancer Patients

Innovative Cancer Resource Navigator Tool Facilitates Easy Search of Leading Online Cancer Resources; Patients Able to Share and Read Inspirational Stories from Across the NationTHOUSAND OAKS,

Amneal Receives FDA Approval for Indomethacin ER Capsules

Four sizes offer flexibility for a variety of dispensing needs BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, LLC is pleased to announce that it received U.S. FDA approval for

DURATION-6 Top-Line Study Results Announced

SAN DIEGO, INDIANAPOLIS and WALTHAM, Mass., March 3, 2011 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today

The Majority of Surveyed U.S. Oncologists Identified FOLFIRINOX as the Most Efficacious Treatment for Advanced Pancreatic

However Most Surveyed MCO Pharmacy Directors Consider Gemcitabine Plus Erlotinib To Be the Most Efficacious Treatment for Advanced Pancreatic Cancer, According to Findings from Decision Resources

DURATION-6 Top-Line Study Results Announced

SAN DIEGO & INDIANAPOLIS & WALTHAM, Mass.--(BUSINESS WIRE)-- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today announced

Global Pharma Company Chooses ESCA Blast to Restore 1.5 M Sq. Ft. WW Headquarters to Sparkling Condition

Global Pharma Company Chooses ESCA Blast to Restore 1.5 M Sq. Ft. WW Headquarters to Sparkling Condition One of the world's largest Princeton, NJ-based pharmaceutical companies was disgusted by an

Humana Inc. to Present at the Cowen and Company 31st Annual Health Care Conference

LOUISVILLE, Ky.--(BUSINESS WIRE)-- Humana Inc. (NYSE: HUM) announced today that James H. Bloem, senior vice president, chief financial officer and treasurer, will make a presentation to investors at

European Commission continues to support Avastin in combination with paclitaxel as an effective treatment option for women with

European Commission continues to support Avastin in combination with paclitaxel as an effective treatment option for women with metastatic breast cancer Roche (SIX: RO, ROG; OTCQX: RHHBY) announced

Handa Pharmaceuticals Announces Submission of Its First-to-File ANDA for Takeda's DEXILANT®

FREMONT, Calif., March 2, 2011 /PRNewswire/ -- Handa Pharmaceuticals, LLC ("Handa"), a specialty pharmaceutical company based in Fremont, California, today confirmed that its Abbreviated New Drug

CVS Caremark Announces Agreement With ActiveHealth Management for Evidence-Based Clinical Decision Support

NEW YORK and WOONSOCKET, R.I., March 2, 2011 /PRNewswire/ -- ActiveHealth Management, an independent subsidiary of Aetna (NYSE: AET), and CVS Caremark (NYSE: CVS) today announced a three-year

World-Class Professional Golfer Phil Mickelson Launches 'On Course with Phil' for People with Certain Inflammatory Joint and Ski

TWO LEADING PATIENT ADVOCATE GROUPS COLLABORATE TO URGE EARLY DIAGNOSIS AND TREATMENTTHOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., March 2, 2011 /PRNewswire/ -- World-class professional golfer and

NBPTS and Amgen Foundation Join to Bolster Science Education

$1.5 Million Grant Will Provide Support For Teachers Seeking National Board CertificationTHOUSAND OAKS, Calif. and ARLINGTON, Va., March 1, 2011 /PRNewswire/ -- The National Board for Professional

Bristol-Myers Squibb Announces Dividend

NEW YORK--(BUSINESS WIRE)-- The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a quarterly dividend of 33 cents ($0.33) per share on the $0.10 par value Common Stock of

Merck’s ISENTRESS® (raltegravir) Demonstrated Durable Reductions in HIV-1 Viral Load and Sustained Tolerability At T

BOSTON--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that new Phase III data showed that adult patients with HIV-1 infection maintained